Table 1 Clinical characteristics of the study participants.
Characteristic | Healthy controls | Patients with CKD (nā=ā25) | Patients on HD (nā=ā29) | p value | ||
|---|---|---|---|---|---|---|
Without DM | With DM | Without DM | With DM | |||
N | 12 | 14 | 11 | 16 | 13 | Ā |
Sex (male, %) | 100 | 36 | 64 | 25 | 8 | 0.001 |
Age | 33.5ā±ā13.5 | 62.5ā±ā16.2 | 64.8ā±ā10.4 | 50.8ā±ā14.7 | 64.6ā±ā12.0 | ā<ā0.0001 |
Height (cm) | 171.0ā±ā4.1 | 158.3ā±ā12.7 | 159.3ā±ā7.3 | 165.8ā±ā5.7 | 166.8ā±ā9.6 | 0.020 |
Weight (kg) | 63.2ā±ā7.8 | 60.8ā±ā15.9 | 69.9ā±ā15.4 | 59.6ā±ā10.4 | 64.2ā±ā13.8 | 0.325 |
Body mass index (kg/m2) | 21.6ā±ā2.4 | 24.0ā±ā4.2 | 27.8ā±ā7.2 | 21.6ā±ā3.3 | 23.0ā±ā3.8 | 0.005 |
Creatinine (mg/dL) | 0.9ā±ā0.1 | 3.3ā±ā2.1 | 2.9ā±ā1.3 | Renal death (13.0ā±ā5.5) | Renal death (8.6ā±ā6.8) | ā<ā0.0001 |
eGFR (mL/min/1.73 m2) | 81.7ā±ā14.6 | 20.3ā±ā16.1 | 21.0ā±ā10.5 | Renal death (4.0ā±ā1.3) | Renal death (12.9ā±ā15.5) | ā<ā0.0001 |
HbA1c (NGSP) (%) | Ā | N/A | 6.3ā±ā0.9 | Ā | Ā | Ā |
Glycoalbumin (%) | Ā | Ā | Ā | N/A | 20.0ā±ā3.3 | Ā |
Systolic blood pressure (mmHg) | 121.5ā±ā8.8 | 140.9ā±ā26.4 | 129.5ā±ā18.5 | 139.5ā±ā30.3 | 149.8ā±ā25.4 | 0.152 |
Diastolic blood pressure (mmHg) | 81.5ā±ā8.0 | 81.8ā±ā18.6 | 73.8ā±ā15.8 | 82.4ā±ā17.5 | 75.5ā±ā12.0 | 0.531 |
Hemoglobin (g/dL) | 15.2ā±ā0.5 | 10.7ā±ā1.6 | 10.3ā±ā2.0 | 10.2ā±ā1.3 | 10.4ā±ā1.8 | ā<ā0.0001 |
Total cholesterol (mg/dL) | 189.2ā±ā8.8 | 202.5ā±ā56.2 | 151.8ā±ā43.6 | 151.9ā±ā25.2 | 126.2ā±ā19.6 | ā<ā0.0001 |
HDL cholesterol (mg/dL) | 54.6ā±ā8.4 | 52.7ā±ā25.7 | 44.3ā±ā11.5 | 48.9ā±ā14.0 | 36.0ā±ā8.9 | 0.068 |
Coronary artery disease (%) | 0 | 0 | 9 | 6 | 15 | 0.446 |
Stroke (%) | 0 | 7 | 0 | 6 | 8 | 0.803 |
Smoking habit (%) | 8 | 57 | 73 | 38 | 38 | 0.020 |